Piper Sandler reiterated coverage on Neuronetics with a new price target

3/2/21 12:02:41 PM ET

Medical/Dental Instruments

Health Care

Piper Sandler reiterated coverage of Neuronetics with a rating of Overweight and set a new price target of $25.00 from $27.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$STIM

Date	Price Target	Rating	Analyst
8/13/2024		Outperform → Mkt Perform	William Blair
10/14/2021	$18.00 → $12.00	Market Outperform	JMP Securities
10/13/2021		Outperform → Mkt Perform	William Blair
10/13/2021		Buy → Neutral	BTIG